Mangiavillano B, Pagano N, Baron TH, Luigiano C. Outcome of stenting in biliary and pancreatic benign and malignant diseases: A comprehensive review. World J Gastroenterol 2015; 21(30): 9038-9054 [PMID: 26290631 DOI: 10.3748/wjg.v21.i30.9038]
Corresponding Author of This Article
Benedetto Mangiavillano, MD, Unit of Gastroenterology and Digestive Endoscopy, General Hospital of Sanremo, Via G. Borea 56, 18038 Sanremo, Italy. b_mangiavillano@hotmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 14, 2015; 21(30): 9038-9054 Published online Aug 14, 2015. doi: 10.3748/wjg.v21.i30.9038
Outcome of stenting in biliary and pancreatic benign and malignant diseases: A comprehensive review
Benedetto Mangiavillano, Nico Pagano, Todd H Baron, Carmelo Luigiano
Benedetto Mangiavillano, Unit of Gastroenterology and Digestive Endoscopy, General Hospital of Sanremo, 18038 Sanremo, Italy
Nico Pagano, Unit of Gastroenterology, Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy
Todd H Baron, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, United States
Carmelo Luigiano, Unit of Digestive Endoscopy, San Paolo Hospital, 20142 Milano, Italy
Author contributions: Mangiavillano B, Pagano N and Luigiano C designed research, wrote the text, performed literature search, analyzed the data, edited and finalized the text; and Baron TH reviewed the paper for important intellectual content.
Conflict-of-interest statement: The authors declare no conflict of interests.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Benedetto Mangiavillano, MD, Unit of Gastroenterology and Digestive Endoscopy, General Hospital of Sanremo, Via G. Borea 56, 18038 Sanremo, Italy. b_mangiavillano@hotmail.com
Telephone: +39-184-536870 Fax: +39-184-536875
Received: April 1, 2015 Peer-review started: April 23, 2015 First decision: April 30, 2015 Revised: May 4, 2015 Accepted: July 8, 2015 Article in press: July 8, 2015 Published online: August 14, 2015 Processing time: 138 Days and 8.8 Hours
Abstract
Endoscopic stenting has become a widely method for the management of various malignant and benign pancreatico-biliary disorders. Biliary and pancreatic stents are devices made of plastic or metal used primarily to establish patency of an obstructed bile or pancreatic duct and may also be used to treat biliary or pancreatic leaks, pancreatic fluid collections and to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis. In this review, relevant literature search and expert opinions have been used to evaluate the outcome of stenting in biliary and pancreatic benign and malignant diseases.
Core tip: Endoscopic stenting plays an indispensable role in the treatment of benign and malignant pancreatico-biliary disorders. This article will cover the indications and outcome of stenting in bilio-pancreatic disease.
